Active intensive monitoring, including PSA testing every six months and repeat MRIs independent of PSA changes, is recommended for patients with low-volume, low-grade prostate cancer on active surveillance.

“we do active intensive monitoring that's PSA testing every six months I still believe that like you were mentioning before following that PSA and if it changes closely is helpful and then we do do you repeat the MRI independent of a change in PSA in those patients once there a 3 plus three I do my general frequency would be um that if they they've had an MRI pre pre-biopsy then I'll track them depending what their if their PSA is stable I will not repeat the biopsy we recommend we recommend a confirmatory biopsy at one year okay so you have low volume low-grade prostate cancer we check your PSA at 6 months it's stable everything looks good your MRI was not concerning we'll do a biopsy for you at one year”